AGÕæÈ˹ٷ½

STOCK TITAN

Hypha Labs Acquires State-of-the-Art HPLC Analytic Machine and Partners with Lucidity Systems for Advanced Autosampler Upgrade

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
partnership acquisition

Hypha Labs (OTCQB:FUNI), a functional mushroom sciences company, has announced two significant technological acquisitions: a new High-Performance Liquid Chromatography (HPLC) analytic machine and early access to Lucidity Systems' variable loop autosampler upgrade. The new equipment will enhance the company's ability to conduct precise measurements and analysis of ²Ñ¾±³¦°ù´Ç±Ê±ð²¹°ù±ô²õâ„� products.

The technological upgrades will enable Hypha Labs to achieve higher potency resolution, more effective peak separation, and unprecedented accuracy in measuring Micropearl active compounds. This advancement is expected to improve research capabilities with their Mushroom Accelerator machine and lead to more consistent product outcomes.

Hypha Labs (OTCQB:FUNI), un'azienda specializzata nelle scienze dei funghi funzionali, ha annunciato due importanti acquisizioni tecnologiche: una nuova macchina analitica a Cromatografia Liquida ad Alte Prestazioni (HPLC) e l'accesso anticipato all'aggiornamento del campionatore automatico a loop variabile di Lucidity Systems. Queste nuove attrezzature miglioreranno la capacità dell'azienda di effettuare misurazioni precise e analisi dei prodotti ²Ñ¾±³¦°ù´Ç±Ê±ð²¹°ù±ô²õâ„�.

Gli aggiornamenti tecnologici permetteranno a Hypha Labs di ottenere una risoluzione di potenza superiore, una separazione più efficace dei picchi e un'accuratezza senza precedenti nella misurazione dei composti attivi delle MicroPearl. Questo progresso è destinato a potenziare le capacità di ricerca con la loro macchina Mushroom Accelerator e a garantire risultati di prodotto più coerenti.

Hypha Labs (OTCQB:FUNI), una empresa especializada en ciencias de hongos funcionales, ha anunciado dos adquisiciones tecnológicas importantes: una nueva máquina analítica de Cromatografía Líquida de Alta Resolución (HPLC) y acceso anticipado a la actualización del muestreador automático de bucle variable de Lucidity Systems. Este nuevo equipo mejorará la capacidad de la empresa para realizar mediciones precisas y análisis de los productos ²Ñ¾±³¦°ù´Ç±Ê±ð²¹°ù±ô²õâ„�.

Las mejoras tecnológicas permitirán a Hypha Labs alcanzar una mayor resolución de potencia, una separación más efectiva de picos y una precisión sin precedentes en la medición de los compuestos activos de MicroPearl. Este avance se espera que mejore las capacidades de investigación con su máquina Mushroom Accelerator y conduzca a resultados de producto más consistentes.

Hypha Labs (OTCQB:FUNI)ëŠ� 기능ì„� 버섯 과학 회사로서, ë‘� 가지 중요í•� 기술ì � ì¸ìˆ˜ë¥� 발표했습니다: 새로ìš� 고성ëŠ� ì•¡ì²´ í¬ë¡œë§ˆí† ê·¸ëž˜í”�(HPLC) ë¶„ì„ ê¸°ê³„ì™€ Lucidity Systemsì� 가변 루프 ìžë™ 시료 채취ê¸� 업그레ì´ë“� 조기 접근권입니다. ì� 새로ìš� 장비ëŠ� 회사가 ²Ñ¾±³¦°ù´Ç±Ê±ð²¹°ù±ô²õâ„� 제품ì� ì •ë°€í•� 측정 ë°� ë¶„ì„ ëŠ¥ë ¥ì� í–¥ìƒì‹œí‚¬ 것입니다.

기술 업그레ì´ë“œë¥¼ 통해 Hypha LabsëŠ� ë� ë†’ì€ íš¨ëŠ¥ í•´ìƒë�, ë”ìš± 효과ì ì¸ í”¼í¬ ë¶„ë¦¬, 그리ê³� MicroPearl 활성 화합ë¬� 측정ì—서 ì „ë¡€ 없는 ì •í™•ì„±ì„ ë‹¬ì„±í•� ìˆ� 있게 ë©ë‹ˆë‹�. ì� ë°œì „ì€ Mushroom Accelerator 기계와 함께 연구 능력ì� í–¥ìƒì‹œí‚¤ê³� 제품 ê²°ê³¼ì� ì¼ê´€ì„±ì„ ë†’ì¼ ê²ƒìœ¼ë¡� 기대ë©ë‹ˆë‹�.

Hypha Labs (OTCQB:FUNI), une entreprise spécialisée dans les sciences des champignons fonctionnels, a annoncé deux acquisitions technologiques majeures : une nouvelle machine analytique de chromatographie liquide haute performance (HPLC) et un accès anticipé à la mise à niveau de l'automate à boucle variable de Lucidity Systems. Ce nouvel équipement améliorera la capacité de l'entreprise à réaliser des mesures précises et des analyses des produits ²Ñ¾±³¦°ù´Ç±Ê±ð²¹°ù±ô²õâ„�.

Les améliorations technologiques permettront à Hypha Labs d'obtenir une résolution de puissance plus élevée, une séparation des pics plus efficace et une précision sans précédent dans la mesure des composés actifs des MicroPearls. Cette avancée devrait renforcer les capacités de recherche avec leur machine Mushroom Accelerator et conduire à des résultats produits plus cohérents.

Hypha Labs (OTCQB:FUNI), ein Unternehmen für funktionelle Pilzwissenschaften, hat zwei bedeutende technologische Anschaffungen bekannt gegeben: ein neues Hochleistungs-Flüssigkeitschromatographie-(HPLC)-Analysegerät und einen frühen Zugang zum Upgrade des variablen Loop-Autosamplers von Lucidity Systems. Die neue Ausrüstung wird die Fähigkeit des Unternehmens verbessern, präzise Messungen und Analysen der ²Ñ¾±³¦°ù´Ç±Ê±ð²¹°ù±ô²õâ„�-Produkte durchzuführen.

Die technologischen Upgrades ermöglichen es Hypha Labs, eine höhere Potenzauflösung, effektivere Peak-Trennung und eine beispiellose Genauigkeit bei der Messung der aktiven MicroPearl-Verbindungen zu erreichen. Dieser Fortschritt wird voraussichtlich die Forschungskapazitäten mit ihrer Mushroom Accelerator-Maschine verbessern und zu konsistenteren Produktergebnissen führen.

Positive
  • Acquisition of advanced HPLC machine enhances analytical capabilities
  • Early access partnership with Lucidity Systems for autosampler upgrade
  • Improved measurement accuracy and potency resolution
  • Enhanced ability to produce more consistent products
Negative
  • None.

LAS VEGAS, NV / / May 1, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce the acquisition of a cutting-edge High-Performance Liquid Chromatography (HPLC) analytic machine, further enhancing our capabilities in precision measurement and analysis. In a strategic partnership with Lucidity Systems, the Company is also thrilled to announce early access to their newly released variable loop autosampler upgrade, designed to elevate the performance of its already advanced machine.

This collaboration allows Hypha Labs to leverage Lucidity Systems' innovative technology, enabling the Company to exercise its advanced methods and techniques at a higher potency resolution. The new autosampler upgrade will significantly enhance the Company's ability to conduct low granular resolution measurements, which is crucial for its ongoing research and development efforts.

With this upgrade, Hyph Labs will be able to separate peaks more effectively and measure the potencies of the Micropearl active compounds with unprecedented accuracy. This advancement will provide the Company with deeper insights, allowing Hypha Labs to fine tune its research more precisely with the revolutionary Mushroom Accelerator machine. This is a win for customers, allowing the Company to produce a more consistent and highly valued product outcome.

"We are thrilled to partner with Lucidity Systems and gain early access to their latest ground-breaking technology," said John Frailey, CTO at Hypha Labs. "This upgrade will not only enhance our analytical capabilities but also empower us to push the boundaries of our research in the field of mycology."

Hypha Labs remains committed to advancing the science of mushroom cultivation equipment and genetic research to accommodate these advances. The integration of this new HPLC machine and the variable loop autosampler upgrade marks a significant milestone in Hypha's journey to deliver innovative solutions and insights to our customers, clients and partners.

Please add Hypha Labs to your Stockhouse "Watchlist" here:

Join the Company's Stockhouse bullboard here:

About Hypha Labs, Inc.

The company has developed revolutionary, cutting-edge technology focused on new methods of producing the active ingredients found in a wide array of functional mushrooms using its patent-pending mushroom accelerators. The Company is positioning itself to play an important role in the burgeoning Functional Mushroom industry in addition to being a disruptive force in future and emerging mushroom opportunities. Visit us at .

SAFE HARBOR FORWARD LOOKING STATEMENTS:

This press release may contain forward looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise. Hypha Labs has paid Stockhouse $15,000 for six months of market awareness services.

From time to time, the Company may post new and material information on its website or through its social media profiles at the links below:

LN:
FB:
IG:
Twitter:

For more information about Hypha Labs visit

For the Company's current Investor Presentation please visit

Investor and Media Relations:

Integrity Media Inc.
(888) 216-3595
[email protected]

SOURCE: Hypha Labs, Inc.



View the original on ACCESS Newswire

FAQ

What new equipment did Hypha Labs (FUNI) acquire in May 2025?

Hypha Labs acquired a High-Performance Liquid Chromatography (HPLC) analytic machine and gained early access to Lucidity Systems' variable loop autosampler upgrade.

How will the new HPLC machine benefit Hypha Labs' operations?

The HPLC machine will enhance Hypha Labs' precision measurement capabilities, enable higher potency resolution, and improve their ability to analyze ²Ñ¾±³¦°ù´Ç±Ê±ð²¹°ù±ô²õâ„� products with greater accuracy.

What is the purpose of the Lucidity Systems autosampler upgrade for FUNI?

The autosampler upgrade will allow for more effective peak separation, higher potency resolution measurements, and more precise research capabilities with their Mushroom Accelerator machine.

How will these technological upgrades impact Hypha Labs' products?

The upgrades will enable Hypha Labs to produce more consistent products with better quality control through improved measurement accuracy and enhanced analytical capabilities.
Hypha Labs

OTC:FUNI

FUNI Rankings

FUNI Latest News

FUNI Stock Data

3.54M
118.30M
14.48%
Diagnostics & Research
Healthcare
United States
Las Vegas